No­van shares shoot up on pos­i­tive PhII an­ti-fun­gal gel boast; Apex­i­gen strikes a check­point com­bo agree­ment with Bris­tol-My­ers

→ Shares of Mor­risville, NC-based No­van Ther­a­peu­tics shot up 35% this morn­ing af­ter the biotech re­port­ed that in­ves­ti­ga­tors reaped pos­i­tive top line da­ta from …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER